Cervical Neuroendocrine Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-11-19
Clinical Trial Update: Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas [Phase 2]
Phase 2 trial evaluating camrelizumab with chemotherapy for recurrent or advanced cervical neuroendocrine carcinomas; status and detailed re…